| |
|
|
Session 15
Oral Abstract Presentations Treatment Strategies Wednesday 11:15 am - 12:45 pm Auditorium |
| Moderators: | Richard Haubrich Univ of California, San Diego |
| 11:15 64 | HIV-NAT 001.4: A Prospective Randomized Trial of Structured Treatment Interruption in Patients with Chronic HIV Infection J. Ananworanich*1,2, P. Cardiello1,3, P. Srasuebkul1,2, T. Samor1,2, E. Hassink3, A. Mahanontharit1,2, T. Boonmangum1,2, W. Apateerapong1,2, A. Hill4, K. Ruxrungtham1,2,5, D. Cooper1,6, J. Lange1,3, P. Phanuphak1,2,5 1HIV Netherlands Australia Thailand Res Collaboration, Thai Red Cross AIDS Res Ctr, Bangkok; 2Thai Red Cross AIDS Res Ctr, Bangkok, Thailand; 3Intl Antiviral Therapy Eval Ctr, Amsterdam, The Netherlands; 4Roche, Welwyn, UK; 5Chulalongkorn Univ, Bangkok, Thailand; and 6Natl Ctr In HIV Epid and Clin Res (NCHECR), Univ of New South Wales, Sydney, Australia |
| 11:30 65 | A Multi-center, Randomized Controlled Clinical Trial of Continuous vs Intermittent HAART Guided by CD4+ T-cell Counts and Plasma HIV-1 RNA Levels L. Ruiz*1, L. Gómez2, P. Domingo3, J. Romeu1, G. Tambussi4, J. Martínez-Picado1, J. Miranda1, J. C. Martínez1, J. M. Llibre5, C. Tural1, G. Sirera1, F. Vidal6, CR. Fumaz1, E. Negredo1, B. Clotet1 1IrsiCaixa Fndn and Lluita contra la SIDA Fndn, Barcelona, Spain; 2Univ Politècnica de Catalunya, Barcelona, Spain; 3Hosp St Pau, Barcelona, Spain; 4Hosp San Raffaele, Milan, Italy; 5Hosp de Calella, Barcelona, Spain; and 6Hosp Joan XXIII, Tarragona, Spain |
| 11:45 66 | ISS-PART: A Prospective, Randomized, Multi-center Clinical Trial of Intermittent Therapy in HIV+ Subjects with Persistent Suppression of Viral Replication S. Vella*, M. Giuliano, L. Palmisano, R. Bucciardini, M. Andreotti, R. Arcieri, V. Fragola, C. Galluzzo, L. Weimer, MF Pirillo, R.Amici, E.Germinario, Italian ISS-PART Clinical Centers Inst Superiore di Sanità, Rome, Italy |
| 12:00 67 | CPCRA 064: A Randomized Trial Examining Structured Treatment Interruption for Patients Failing Therapy with Multi-drug Resistant HIV J. Lawrence*1, D. Mayers2, K. Huppler Hullsiek3, G. Collins3, D. Abrams1, R. Reisler4, L. Crane5, B. Schmetter6, T. Dionne7, J. Saldanha8, M. Jones1, J. Baxter9, the CPCRA 064 Study Team of the Terry Beirn Community Programs for Clinical Research on AIDS. 1Univ of California at San Francisco; 2Henry Ford Hosp, Detroit, MI; 3Univ of Minnesota, Minneapolis; 4Natl Inst of Hlth, NIAID, Div of AIDS, Bethesda, MD; 5Wayne State Univ, Detroit, MI; 6Social and Sci Sys, Silver Spring, MD; 7Veterans Admin Med Ctr, Washington, DC; 8Denver Publ Hlth Dept, CO; and 9Cooper Hosp /RWJ Med Sch, Camden, NJ |
| 12:15 68 | Long-term Benefit of Treatment Interruption in Salvage Therapy (GIGHAART ANRS 097) christine katlama*1, stephanie dominguez1, claudine duvivier1, constance delaugerre1, gilles peytavin2, mayeule legrand1, vincent calvez1, karine gourlain1, dominique costagliola3 1Hosp Pitié Salpêtrière, Paris, France; 2Hosp Bichat-Claude Bernard, Paris, France; and 3INSERM E 0214, Paris, France |
| 12:30 68lb | A Randomized, Controlled Trial of Long Cycle Structured Intermittent Versus Continuous ARV Therapy for Chronic HIV Infection M Dybul*1, E Nies-Kraske2, M Daucher2, C Hallahan2, G Csako3, C Yoder4, L Ehler4, P Sklar4, M Belson4, B Hidalgo4, J Metcalf4, R Davey4, D Rock Kress4, A Fauci4 1NIAID,NIH, DHHS, Bethesda, MD; 2NIAID, NIH, DHHS, Bethesda, MD; 3WG Magnuson Clinical Center, NIH, Bethesda, MD; and 4NIAID, NIH, Bethesda, MD |